Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success
- 1 April 2018
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 275, 254-268
Abstract
No abstract availableKeywords
Funding Information
- BPI-France
This publication has 130 references indexed in Scilit:
- The Interactions between Blood and Polymeric Nanoparticles Depend on the Nature and Structure of the Hydrogel Covering the SurfacePolymers, 2012
- Challenges in Development of Nanoparticle-Based TherapeuticsThe AAPS Journal, 2012
- The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfacesBiomaterials, 2011
- Automated electron microscopy for evaluating two-dimensional crystallization of membrane proteinsJournal of Structural Biology, 2010
- Modern Uses of Electron Microscopy for Detection of VirusesClinical Microbiology Reviews, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groupsBiomaterials, 2009
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- TheNeisseria meningitidisCapsule Is Important for Intracellular Survival in Human CellsInfection and Immunity, 2007